| PERIOD ENDING | 31-Jan-09 | 2-Feb-08 | 3-Feb-07 | | Total Revenue | 8,573,000 | 8,828,000 | 8,560,698 | | Cost of Revenue | 5,417,000 | 5,526,000 | 5,353,949 | | | Gross Profit | 3,156,000 | 3,302,000 | 3,206,749 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,386,000 | 2,360,000 | 2,296,863 | | Non Recurring | (9,000) |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 779,000 | 942,000 | 909,886 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,000 | 305,000 | 253,179 | | Earnings Before Interest And Taxes | 782,000 | 1,321,000 | 1,163,065 | | Interest Expense | 134,000 | 74,000 | 57,412 | | Income Before Tax | 648,000 | 1,247,000 | 1,105,653 | | Income Tax Expense | 247,000 | 458,000 | 427,654 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 401,000 | 715,000 | 677,999 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 401,000 | 715,000 | 677,999 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $401,000 | $715,000 | $677,999 |
|
0.16% Nasdaq 0.00%
Income Statement
